← Browse by Condition
Medical Condition
atypical hemolytic uremic syndrome
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3
NCT05795140 Phase 3
Recruiting
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
Enrollment
125 pts
Location
Brazil, China, Czech...
Sponsor
Novartis Pharmaceuticals
NCT01793168
Recruiting
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Enrollment
20,000 pts
Location
United States, Austr...
Sponsor
Sanford Health
NCT06065852
Recruiting
National Registry of Rare Kidney Diseases
Enrollment
35,000 pts
Location
United Kingdom
Sponsor
UK Kidney Association